Table 1.
Study and study participants characteristics (n = 7)
|
Study, Year |
Study Design | Setting and Geographic Location | Collection Year | Data Domain |
Sample Size (% women) |
Age (years) | BMI (kg/m2) | Duration of Symptoms (months) |
|---|---|---|---|---|---|---|---|---|
|
Dunn et al., 2004 [4] |
Population-based cohort | Community in the USA | 2001–2002 | Prevalence |
784 (56.7%) |
74.5 ± 6.0 | 38% had BMI ≥ 30 | NA |
|
Yi et al., 2011 [9] |
Retrospective review of medical records | Foot clinic at a general hospital in South Korea | 2008 | Prevalence & diagnostic criteria |
250 (54.4%) |
43.8 ± 12.0 | NR | 13.3 ± 17.4 |
|
Kanatli et al., 2001 [15] |
Observational case–control | NR in Turkey | NR | Etiology |
106 contributing 188 feet (56.6%) |
34.8 ± 12.9 | 26.1 ± 5.6 | NR |
|
Lopez-Lopez et al., 2019 [16] |
Observational case–control | Podiatry department at a medical center in Spain | 2008–2015 | Etiology and diagnostic criteria |
375 (47.2%) |
44.7 ± 14.1 | 26.5 ± 5.8 | NR |
|
Balius et al., 2021 [17] |
Observational case series | Outpatient clinic of sports medicine and rheumatology in Spain | NR | Etiology |
9 (NR) |
31 ± 8.5 | NR | 2.46 ± 3.72 |
|
Lin et al., 2017 [18] |
Single case study | NR in Taiwan | NR | Intervention |
1 male (0%) |
33 | NR | 36 + |
|
Chae et al., 2018 [19] |
Quasi-experimental intervention (no control group) | Foot clinic at a general hospital in South Korea | 2015–2016 | Intervention |
19 contributing 32 feet (73.7%) |
51.5 ± 14.1 | 22.6 ± 2.6 | NR |
Abbreviations: NA Not applicable, NR Not reported